- Home
- SMJF vs BDTX Comparison
SMJF vs BDTX Comparison
Compare SMJF & BDTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SMJF | BDTX |
|---|---|---|
| Founded | 1988 | 2014 |
| Country | Singapore | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 123.8M | 148.1M |
| IPO Year | 2025 | 2020 |
Fundamental Metrics
Financial Performance| Metric | SMJF | BDTX |
|---|---|---|
| Price | $5.18 | $2.65 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $10.40 |
| AVG Volume (30 Days) | 539.4K | ★ 989.2K |
| Earning Date | 01-01-0001 | 03-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | 0.03 | ★ 0.38 |
| Revenue | $12,533,617.00 | ★ $70,000,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $166.91 | ★ $6.80 |
| Revenue Growth | ★ 1.51 | N/A |
| 52 Week Low | $4.25 | $1.20 |
| 52 Week High | $7.00 | $4.94 |
Technical Indicators
Market Signals| Indicator | SMJF | BDTX |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 46.72 |
| Support Level | N/A | $2.36 |
| Resistance Level | N/A | $2.83 |
| Average True Range (ATR) | 0.00 | 0.16 |
| MACD | 0.00 | 0.02 |
| Stochastic Oscillator | 0.00 | 55.77 |
Price Performance
Historical ComparisonAbout SMJF SMJ International Holdings Inc. Class A Ordinary Shares
SMJ International Holdings Inc specializes in the sale and distribution of a wide range of flooring products such as carpet tiles, broadloom carpets and vinyl tiles. The company operates under the proprietary brand 'SMJ'.The company also supplies environmentally friendly flooring products, promoting sustainable building practices in Asia. It has presence in several countries including Malaysia, Indonesia, Philippines, Hong Kong, PRC, Taiwan, Korea, Thailand, Vietnam, Brunei, and India. It generates revenue mainly through the sale and distribution of its flooring products prominently in Singapore.
About BDTX Black Diamond Therapeutics Inc.
Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.